ANDA 65455, held by Hospira Inc. Vancomycin Hydrochloride.
As of Nov 16, 2026, ANDA 65455 (Vancomycin Hydrochloride), held by Hospira Inc, was first approved by FDA on Apr 29, 2009, with 3 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 29, 2009 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Vancomycin HydrochlorideEQ 10GM BASE/VIAL · injectable;injection | Vancomycin Hydrochloride | Discontinued |
| May 24, 2021 | Supplement 18Labeling · Standard review | Approved | None posted |
| Aug 28, 2020 | Supplement 6Labeling · Standard review | Approved | None posted |
| Aug 28, 2020 | Supplement 14Labeling · Standard review | Approved | None posted |
| Apr 29, 2009 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters